Phase II study of pentosan polysulfate (PPS) in patients with AIDS-related Kaposi's sarcoma

Tumori

Volumn 82, Issue 4, 1996, Pages 360-363

  Schwartsmann, Gilberto ^a,c,e   Sprinz, Eduardo ^a   Kalakun, Luciane ^a,c   Yamagushi, Nise ^b   Sander, Ernesto ^a,c,d   Grivicich, Ivana ^c   Koya, Richard ^a   Mans, Dennis Ricardo August ^a,c  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c S Amer Off Anticancer Drug D   (Brazil)

^d NATIONAL CANCER INSTITUTE   (United States)

^e HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

acquired immunodeficiency syndrome (AIDS); Kaposi's sarcoma; pentosan polysulfate

Indexed keywords

DIDANOSINE; ETOPOSIDE; MEGESTROL ACETATE; PENTOSAN POLYSULFATE; VINCRISTINE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KAPOSI SARCOMA; MALE; ORAL DRUG ADMINISTRATION; PHASE 2 CLINICAL TRIAL;

EID: 0029803230     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089169608200412     Document Type: Article

References (15)

1. Safai B., Schwartz J.J.: Kaposi's Sarcoma and the acquired immunodeficiency syndrome. In: Aids: etiology, diagnosis, treatment and prevention, De Vitta V.T., Hellman S., Rosenbers S.A. (Eds.). Philadelphia, Pensylvania, USA, Lippincott Company, 209-23, 1992.
2. Mitsuyasu R.T., Taylor J.M.G., Glaspy J., Fahey J.L.: Heterogeneity of epidemic Kaposi's sarcoma. Cancer, 57: 1657-61, 1986.
3. Gill P.S., Rarick M., McCutchan J.A., Slater L., Parker B., Muchmore E., Bernstein-Singer M., Akil B., Spina B.M., Krauo M. Levine A.: Systemic treatment of Aids-related Kaposi's sarcoma: results of a randomized trial. Am J. Med., 90: 427-33, 1991.
4. Gross J.L., Herblin W., Dusak A., Czerniak P., Diamond M.D., Sun T., Eidsvoog K., Dexter D.L., Yayon A.: Effects of modulation of basic fibroblast growth factor on tumor growth in vivo. J. Natl. Cancer Inst., 85: 121-131, 1993.
5. Parker B.W., Swain S.M., Zugmaier G., DeLap L.R., Lippman M.E., Wellstein A.: Detectable inhibition of heparin-binding growth factor activity in sera from patients treated with pentosan polysulfate. J. Natl. Cancer Inst., 85: 1068-1073, 1993.
6. Wellstein A., Zugmaier G., Califano III J.A., Soonmyoung P., Lippman M.E.: Tumor growth dependent on Kaposi's sarcoma-derived fibroblast growth factor inhibited by pentosan polysulfate. J. Natl. Cancer Inst., 83: 717-720, 1991.
7. Zugmaier G., Lippman M.E., Wellstein A.: Inhibition by pentosan polysulfate (PPS) of heparin-binding growth factors released from tumor cells and blockage by PPS of tumor growth in animals. J. Natl. Cancer Inst., 84: 1716-1724, 1992.
8. Pluda J.M., Shay L.E., Foli A., Tannenbaum S., Cohen P.J., Goldspiel B.R., Adamo D., Cooper M.R., Broder S., Yarchoan R.: Administration of pentosan polysulfate to patients with human immunodeficiency virus-associated Kaposi's sarcoma. J. Natl. Cancer Inst., 85: 1585-1592, 1993.
9. Schwartsmann G., Wanders J., Koier I.J., Franklin H.R., Dalesio O., Hornstra H.W., van Glabbeke M., Renard J., Van Oosterom A.T., Kaye S.B., Pinedo H.M.: EORTC new drug development - NDD - office coordinating and monitoring program for phase I and II trials with new anticancer agents. Eur. J. Cancer, 27: 1162-1168, 1991.
10. Gehan E.A.: The determination of the number of patients required in a preliminary and follow-up trial of a new chemotherapeutic agent. J. Chronic Dis., 13: 346-349, 1961.
11. Mintzer D.M., Real F.X., Jovino L., Krown S.E.: Treatment of Kaposi's sarcoma and thrombocytopenia with vincristine in patients with the acquired immunodeficiency syndrome. Ann. Intern. Med., 102: 200-2, 1985.
12. Schwartsmann G., Sprinz E., Kronfeld M., Vinholes J., Sander E., Zampese M., Preger R., Kalakun L., Brunetto A.L.: Phase II study of teniposide in patients with AIDS-related Kaposi's sarcoma. Eur. J. Cancer, 27: 1637, 1991.
13. Mans D.R.A., Prolla G., Sander E.: A phase II and plasma pharmacokinetic study of low dose, oral etoposide (VP-16) in advanced AIDS-associated Kaposi's sarcoma (AIDS-KS). Ann. Oncol. 5 (suppl 8): 5, 1994.
14. Schwartsmann G., Sander E., Prolla G., Sprinz E., Zampese M., Vinholes J., Jung F., Kronfeld M., Kalakun L., Mans D.R.A., Brunetto A.L.: Phase II trial of pentosan polysulfate (PPS) in patients with AIDS-related Kaposi's sarcoma. Proc. ASCO, 12:54, 1993.
15. Gasparini G., Harris A.L.: Clinical importance of the determination of tumor angiogenesis in breast carcinoma: much more than a new prognostic tool. J. Clin. Oncol., 13: 765-782, 1995.